The role of inflammation in gastric cancer

Advances in Experimental Medicine and Biology

Volumn 816, Issue , 2014, Pages 235-257

  Şenol, Kazim ^a   Özkan, Murat Bulut ^a   Vural, Selahattin ^a   Tez, Mesut ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GAMMA INTERFERON; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLACEBO; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE; CYTOKINE; GROWTH FACTOR; HORMONE; HORMONE RECEPTOR; INTERLEUKIN 10; MATRIX METALLOPROTEINASE; NEUROTRANSMITTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; COX 2 GENE; DIET SUPPLEMENTATION; ERADICATION THERAPY; GASTRECTOMY; HUMAN; IL 1BETA GENE; IL 6 GENE; IL 8 GENE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RISK REDUCTION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TNF A GENE; TNF ALPHA GENE; ADAPTIVE IMMUNITY; APOPTOSIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); CYTOKINE RELEASE; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; GENETIC RISK; HEREDITY; IMMUNOREGULATION; INFECTION CONTROL; INNATE IMMUNITY; MOLECULAR MECHANICS; PARASITOSIS; STOMACH ADENOCARCINOMA;

EID: 84959250643     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-348-837-8_10     Document Type: Article

References (157)

1. Abnet CC, Freedman ND, Kamangar F, Leitzmann MF, Hollenbeck AR, Schatzkin A (2009) Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a c ohort study and a meta-analysis. Br J Cancer 100(3):551-557. doi:10.1038/sj.bjc.6604880
2. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3(9):745-756. doi:10.1038/nri1184
3. Akaike T, Okamoto S, Sawa T, Yoshitake J, Tamura F, Ichimori K, Miyazaki K, Sasamoto K, Maeda H (2003) 8-nitroguanosine formatio n in viral pneumonia and its implication for pathogenesis. Proc Nat Acad Sci USA 100(2):685-690. doi:10.1073/pnas.0235623100
4. Ashizawa T, Okada R, Suzuki Y, Takagi M, Yamazaki T, Sumi T, Aok i T, Ohnuma S, Aoki T (2005) Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric Cancer (Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association) 8(2):124-131. doi:10.1007/s10120-005-0315-x
5. Balkwill F, Joffroy C (2010) TNF: a tumor-suppressing factor or a tumor-promoting factor? Future Oncol 6(12):1833-1836. doi:10.2217/fon.10.155
6. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539-545. doi:10.1016/S0140-6736(00)04046-0
7. Beachy PA, Karhadkar SS, Berman DM (2004) Tissue repair and stem cell renewal in carcinogenesis. Nature 432(7015):324-331. doi:10.1038/nature03100
8. Beales IL (2002) Effect of interlukin-1beta on proliferation of gastric epithelial cells in culture. BMC Gastroenterol 2:7
9. Ben-Neriah Y, Karin M (2011) Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 12(8):715-723. doi:10.1038/ni.2060
10. Bollag B, Chu ke WF, Frisque RJ (1989) Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: identification of sequences important for efficient transformation. J Virol 63(2):863-872
11. Bos JL (1988) The ras gene family and human carcinogenesis. Mutat Res 195(3):255-271
12. Bromberg J, Wang TC (2009) Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15(2):79-80. doi:10.1016/j.ccr.2009.01.009
13. Chiba T, Marusawa H, Ushijima T (2012) Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation . Gastroenterology 143(3):550-563. doi:10.1053/j.gastro.2012.07.009
14. Corda S, Laplace C, Vicaut E, Duranteau J (2001) Rapid reactive oxygen species production by mitochondria in endothelial cel ls exposed to tumor necrosis factor-alpha is mediated by ceramide. Am J Respir Cell Mol Biol 24(6):762-768
15. Correa P (1988) A human model of gastric carcinogenesis. Cancer Res 48(13):3554-3560
16. Correa P (1995) Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 19 (Suppl 1):S37-S43
17. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860-867. doi:10.1038/nature01322
18. Crusius JB, Canzian F, Capella G, Pena AS, Pera G, Sala N, Agudo A, Rico F, Del Giudice G, Palli D, Plebani M, Boeing H, Bueno-de-Mesquita HB, Carneiro F, Pala V, Save VE, Vineis P, Tumino R, Panico S, Berglund G, Manjer J, Stenling R, Hallmans G, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros JR, Allen N, Key TJ, Bi n ghan S, Caldas C, Linseisen J, Kaaks R, Overvad K, Tjonneland A, Buchner FC, Peeters PH, Numans ME, Clavel-Chapelon F, Trichopoulou A, Lund E, Jenab M, Rinaldi S, Ferrari P, Riboli E, Gonzale z CA (2008) Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol (Official Journal of the European Society for Medical Oncology /ESMO) 19(11):1894-1902. doi:10.1093/annonc/mdn400
19. Dannenberg AJ Altorki NK Boyle JO Dang C Howe LR Weksler BB Subbaramaiah K 2001 Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer Lancet Oncol1 2 9 544-551 doi:10.1016/S1470-2045(01)00488-0
20. de Oliveira JG, Rossi AF, Nizato DM, Miyasaki K, Silva AE (2012) Profiles of gene polymorphisms in cytokines and toll-like receptors with higher risk for gastric cancer. Dig Dis Sci. doi:10.1007/s10620-012-2460-5
21. de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6(1):24-37. doi:10.1038/nrc1782
22. Demple B, Harrison L (1994) Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem 63:915-948. doi:10.1146/annurev.bi.63.070194. 004411
23. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21(2):137-148. doi:10.1016/j.immuni.2004.07.017
24. Dyson N, Bernards R, Friend SH, Gooding LR, Hassell JA, Major EO, Pipas JM, Vandyke T, Harlow E (1990) Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol 64(3):1353-1356
25. El-Omar EM (2001) The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 48(6):743-747
26. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF Jr, Rabkin CS (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404(6776):398-402. doi:10.1038/35006081
27. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF Jr, Chow WH (2003) Increas ed risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124(5):1193-1201
28. Ernst PB, Peura DA, Crowe SE (2006) The translation of Helicobacter py lori basic research to patient care. Gastroenterology 130(1):188-206; quiz 212-183. doi:10.1053/j.gastro.2005.06.032
29. Evans MD, Dizdaroglu M, Cooke MS (2004) Oxidative DNA damage and disease: induction, repair and significance. Mutat Res 567(1):1-61. doi:10.1016/j.mrrev. 2003.11.001
30. Farinati F, Cardin R, Degan P, Rugge M, Mario FD, Bonvicini P, Naccarato R (1998) Oxidative DN A damage accumulation in gastric carcinogenesis. Gut 42(3):351-356
31. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C (2007) Chronic inflammation and oxidative stress in human carcin ogenesis. Int J Cancer 121(11):2381-2386. doi:10.1002/ijc.23192
32. Fedi P, Kimmelman A, Aaronson SA (2000) Growth factor signal transduction in cancer. In: Bast RC Jr, Kufe DW, Pollock RE et al (ed) Holland-Frei cancer medicine, 5th edn. BC Decker, Hamilton (ON). http://www.ncbi.nlm.nih.gov/books/ NBK20800
33. Forones NM, Mandowsky SV, Lourenco LG (2001) Serum levels of interleukin-2 and tumor necrosis factor-alpha correlate to tumor progression in gastric cancer. Hepatogastroenterology 48(40):1199-1201
34. Fox JG, Wang TC (2007) Inflammation, atrophy, and gastric cancer. J Clin Investig 117(1):60-69. doi:10.1172/JCI30111
35. Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, Grilli D, Bazzoli F (2009) Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastr ic cancer? Ann Intern Med 151(2):121-128
36. Furuta S, Goto H, Niwa Y, Ohmiya N, Kamiya K, Oguri A, Hayakawa T, Mori N (2002) Interferon-gamma regulates apoptosis by releasing soluble tumor necrosis factor receptors in a gastric epithelial cell line. J Gastroenterol Hepatol 17(12):1283-1290
37. Furuya Y, Ichikura T, Mochizuki H, Shinomiya N (2000) Relationship between interleukin-1-alpha concentration in tumors and cell growth in gastric cancer, determined using flow cytometry. Gastric Cancer (Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association) 3(2):86-90
38. Gangopadhyay A, Lazure DA, Thomas P (1998) Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis 16(8):703-712
39. Giraud AS, Menheniott TR, Judd LM (2012) Targeting STAT3 in gastric cancer. Expert Opin Ther Targets 16(9):889-901. doi:10.1517/14728222.2012.709238
40. Gomceli I Demiriz B Tez M 2012 Gastric carcinogenesis World J Gastroenterol 18 37 5164-5170. doi:10.3748/wjg.v18.i37.5164
41. Goossens V, Grooten J, De Vos K, Fiers W (1995) Direct evidence for tumor necrosis factorindu ced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 92(18):8115-8119
42. Gorouhi F, Islami F, Bahrami H, Kamangar F (2008) Tumour-necrosis fact or-A polymorphisms and gastric cancer risk: a meta-analysis. Br J Cancer 98(8):1443-1451. doi:10.1038/sj.bjc.6604277
43. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883-899. doi:10.1016/j.cell.2010.01.025
44. Group G, Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M, Va n Cutsem E, Buyse M (2010) Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303(17):1729-1737. doi: 10.1001/jama.2010.534
45. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392(6674):402-405. doi:10.1038/32918
46. Gutierrez-Gonzalez L, Wright NA (2008) Biology of intestinal metaplasia in 2008: more than a simple phenotypic alteration. Digestive and Liver Disease (Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver) 40(7):510-522. doi:10.1016/j.dld.2008. 02.029
47. Halazonetis TD, Gorgoulis VG, Bartek J (2008) An oncogene-induced DNA damage model for cancer development. Science 319(5868):1352-1355. doi:10.1126/science.1140735
48. Handa O, Naito Y, Yoshikawa T (2010) Helicobacter pylori: a ROS-inducing bacterial species in the stomach. Inflam Res (Official Journal of the European Histamine Research Society [et al]) 59(12):997-1003. doi:10.1007/s00011-010- 0245-x
49. Hoffmann W (2008) Regeneration of the gastric mucosa and its glands from stem cells. Curr Med Chem 15(29):3133-3144
50. Hofseth LJ , Saito S, Hussain SP, Espey MG, Miranda KM, Araki Y, Jhappan C, Higashimoto Y, He P, Linke SP, Quezado MM, Zurer I, Rotter V, Wink DA, Appella E, Harris CC (2003) Nitric oxide-induced c ellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci USA 100(1):143-148. doi:10.1073/pnas.0237083100
51. Hoggart K, Lees L, Davies A (2002) Researching human geography.
52. Hodder Arnold Hong Y, Ge Z, Jing C, Shi J, Dong X, Zhou F, Wang M, Zhang Z, Gong W (2013) Functional promoter ?308GA variant in tumor necrosis factor alpha gene is associated with risk and progression of gastric cancer in a Chinese population. PLoS ONE 8(1):e50856. doi:10.1371/journal.pone.0050856
53. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350(6317):427-428. doi:10.1038/350427a0
54. Huang SP, Wu MS, Shun CT, Wang HP, Lin MT, Kuo ML, Lin JT (2004) Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J Biomed Sci 11(4):517-527. doi:10.1159/000077902
55. Hussain SP, Harris CC (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121(11):2373-2380. doi:10.1002/ijc.23173
56. Ikeguchi M, Hatada T, Yamamoto M , Miyake T, Matsunaga T, Fukumoto Y, Yamada Y, Fukuda K, Saito H, Tatebe S (2009) Serum interleukin-6 and-10 levels in patients with gastric cancer. Gastric Cancer (Official Journal of the International Gastric Ca ncer Association and the Japanese Gastric Cancer Association) 12(2):95-100. doi:10.1007/s10120-009-0509-8
57. Inoue S, Kawanishi S (1995) Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett 371(1):86-88
58. Isomoto H, Matsushima K, Inoue N, Hayashi T, Nakayama T, Kunizaki M, Hidaka S, Nakayama M, Hisatsune J, Nakashima M, Nagayasu T, Nakao K, Hirayama T (2012) Interweaving microRNAs and proinflammatory cytokines in gastric mucosa with reference to H. pylori infection. J Clin Immunol 32(2):290-299. doi:10.1007/s10875-011-9626-3
59. Ito R, Ya sui W, Kuniyasu H, Yokozaki H, Tahara E (1997) Expression of interleukin-6 and its effect on the cell growth of gastric carcinoma cell lines. Jpn J Cancer Res: Gann 88(10):953-958
60. Jaiswal M, La Russo NF, Burgart LJ, Gores GJ (2000) Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 60(1):184-190
61. Jayaprakash V, Marshall JR (2011) Selenium and other antioxidants for chemoprevention of gastrointestinal cancers. Best Pract Res Clin Gastroenterol 25(4-5):507-518. doi:10.1016/j.bpg.2011.09.006
62. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90. doi:10.3322/caac.20107
63. Karin M (2006) NF-kappaB and ca ncer: mechanisms and targets. Mol Carcinog 45(6):355-361. doi:10.1002/mc.20217
64. Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer Development and progression. Nat Rev Immunol 5(10):749-759. doi:10.1038/nri1703
65. Kato M, Asaka M (2012) Recent development of gastric cancer prevention. Jpn J Clin Oncol 42(11):987-994. doi:10.1093/jjco/hys151
66. Katoh M (2007) Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev 3(1):30-38
67. Kawabata T, Ichikura T, Majima T, Seki S, Chochi K, Takayama E, Hiraide H, Mochizuki H (2001) Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma. Cancer 92(8):2050-2055
68. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A (2007) Tumor growth need not be driven by rare cancer stem cells. Science 317(5836):337. doi:10.1126/science.1142596
69. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87(2):159-170
70. Kobayashi M, Tsubono Y, Sasazuki S, Sasaki S, Tsugane S, Group JS (2002) Vegetables, fruit and risk of gastric cancer in Japan: a 10-year follow-up of the JPHC Study Cohort I. Int J Cancer 102(1):39-44. doi:10.1002/ijc.10659
71. Konturek PC, Kania J, Konturek JW, Nikiforuk A, Konturek SJ, Ha hn EG (2003) H. pylori infection, atrophic gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired apoptosis in gastric carcinogenesis. Med Sci Monit: Int Med J Exp Clin Res 9(7):SR53-SR66
72. Kuai WX, Wang Q , Yang XZ, Zhao Y, Yu R, Tang XJ (2012) Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells. World J Gastroenterol 18(9):979-985. doi:10.3748/wjg.v1 8.i9.979
73. Kumar R (2010) Microfilariae in lymph node aspirate associated with metastatic gastric carcinoma: a case report. Acta Cytol 54(3):319-320
74. Kuraishy A, Karin M, Grivennikov SI (2011) Tumor promotion via injury-and death-induced inflammation. Immunity 35(4):467-477. doi:10.1016/j.immuni.2011. 09.006
75. Leach SA, Thompson M, Hill M (1987) Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach. Carcinogenesis 8(12):1907-1912
76. Lee JM, Kim SS, Cho YS (2012) The role of PPARgamma in Helicobacter pylori infection and gastric carcinogenesis. PPAR Res 2012:687570. doi:10.1155/2012/687570
77. Leek RD, Landers R, Fox SB, Ng F, Harris AL, Lewis CE (1998) Association of tumour necrosis factor alpha and its receptors with thymidine phospho rylase expression in invasive breast carcinoma. Br J Cancer 77(12):2246-2251
78. Lickert H, Kispert A, Kutsch S, Kemler R (2001) Expression patterns of Wnt genes in mouse gut development. Mech Dev 105(1-2):181-184
79. Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104(4):487-501
80. Luo JL, Kamata H, Karin M (2005) IKK/NF-kappaB signaling: balancing life and death-A new approach to cancer therapy. J Clin Investig 115(10):2625-2632. doi:10.1172/JCI26322
81. Ma J, Sawai H, Matsuo Y, Ochi N, Yasuda A, Takahashi H, Wakasugi T, Funahashi H, Sato M, Okada Y, Takeyama H, Manabe T (2008) Interleukin-1alpha enhances angiogenesis and is associated with liver metastatic potential in human gastric ca ncer cell lines. J Surg Res 148(2):197-204. doi:10.1016/j.jss.2007. 08.014
82. Ma XM, Yu H, Huai N (2009) Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma. World J Gastroenterol 15(31):3874-3883
83. Macarthur M, Hold GL, El-Omar EM (2004) Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286(4):G515-G520. doi:10.1152/ajpgi.00475.2003
84. Macri A Versaci A Loddo S Scuderi G Travagliante M Trimarchi G Teti D Famulari C 2006Serum levels of interleukin 1beta, interleukin 8 and tumour necrosis facto r alpha as markers of gastric cancer Biomarkers (Biochemical indicators of exposure, response, and susceptibility to chemicals11 2 184-193 doi:10.1080/13547500600565677
85. Maeda H, Akaike T (1998) N itric oxide and oxygen radicals in infection, inflammation, and cancer. Biochem Biokhim 63(7):854-865
86. Maehata Y, Nakamura S, Fujisawa K, Esaki M, Moriyama T, Asano K, Fuyuno Y, Yamaguchi K, Egashira I, Kim H, Kanda M, Hirahashi M, Matsumoto T (2012) Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointes t Endosc 75(1):39-46. doi:10.1016/j.gie.2011.08.030
87. Magnus HA (1937) Observations on the presence of intestinal epithelium in the gastric mucosa. J Pathol Bacteriol 44(2):389-398
88. Majima T, Ichikura T, Chochi K, Kawabata T, Tsujimoto H, Sugasawa H, Kuranaga N, Takayama E, Kinoshita M, Hiraide H, Seki S, Mochizuki H (2006) Exploitation of interleukin-18 by gastric cancers fo r their growth and evasion of host immunity. Int J Cancer 118(2):388-395. doi:10.1002/ijc.21334
89. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1(8390):1311-1315
90. Matsushima K, Isomoto H, Inoue N, Nakayama T, Hayashi T, Nakayama M, Nakao K, Hirayama T, Kohno S (2011) MicroRNA signatures in Helicobac ter pylori-infected gastric mucosa. Int J Cancer 128(2):361-370. doi:10.1002/ijc.25348
91. Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P (2005) Long term fo llow up of patients treated for Helicobacter pylori infection. Gut 54(11):1536-1540. doi:10.1136/gut.2005.072009
92. Milne AN, Carneiro F, O'Morain C, Offerhaus GJ (2009) Nature meets nurture: mol ecular genetics of gastric cancer. Hum Genet 126(5):615-628. doi:10.1007/s00439-009-0722-x
93. Misleh JG, Santoro P, Strasser JF, Bennett JJ (2013) Multidisciplinary management of gastric cancer. Surg Oncol Clin N Am 22(2):247-264. doi:10.1016/j.soc.2012.12.013
94. Mochizuki Y, Nakanishi H, Kodera Y, Ito S, Yamamura Y, Kato T, Hibi K, Akiyama S, Nakao A, Tatematsu M (2004) TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line. Clin Exp Metastasis 21(1):39-47
95. Morita D, Ichikura T, Mochizuki H (2001) The expression of PPAR gamma in gastric cancer. Nihon rinsho Jpn J Clin Med 59(Suppl 4):595-597
96. Morson BC (1955) Intestinal metaplasia of the gastric mucosa. Br J Cancer 9(3):365-376
97. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Y uan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410(6824):50-56. doi:10.1038/35065016
98. Nakay ama Y, Shibao K, Sako T, Ohta R, Onitsuka K, Hirata K, Nagata N, Itoh H (2000) Serum levels of interleukin-12 in patients with gastrointestinal cancer. Anticancer Res 20(1C):635-640
99. Nardone G , Rocco A, Malfertheiner P (2004) Review article: helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther 20(3):261-270. doi:10.1111/j.1365-2036.2004.02075.x
100. Nathan C (2002) Points of control in inflammation. Nature 420(6917):846-852. doi:10.1038/nature01320
101. Nowicki A, Szenajch J, Ostrowska G, Wojtowicz A, Wojtowicz K, Kruszewski AA, Maruszynski M, Aukerman SL, Wiktor-Jedrzejczak W (1996) Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, m acrophage-deficient op/op mouse: evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma. Int J Cancer 65(1):112-119. doi:10.1002/(SICI)1097-0215(19960103) 65:13.0.CO;2-I
102. Ogum a K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S, Hirao A, Saya H, Taketo MM, Oshima M (2008) Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells. EM BO J 27(12):1671-1681. doi:10.1038/emboj.2008.105
103. Ooi CH, Ivanova T, Wu J, Lee M, Tan IB, Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, Cheng LL, Lee J, Rha SY, Chun g HC, Ganesan K, So J, Soo KC, Lim D, Chan WH, Wong WK, Bowtell D, Yeoh KG, Grabsch H, Boussioutas A, Tan P (2009) Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet 5(10):e1000676. doi:10.1371/journal.pgen.1000676
104. Oshima H, Matsunaga A, Fujimura T, Tsukamoto T, Taketo MM, Oshima M (2006) Carcinogenesis in mouse stomach by simultaneous activation o f the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 131(4):1086-1095. doi:10.1053/j.gastro.2006.07.014
105. Park S Kim YS Kim YJ Kyung SY Park JW Jeong SH Lee SP (2012) Toxocariasis masquerading as liver and lung metastatic nodules in patents with gastrointestinal cancer: clinicopathologic study of five cases Dig Dis Sci 57 1 155-160t doi:10.1007/s10620-011-1833-5
106. Pereira C, Medeiros RM, Dinis-Ribeiro MJ (2009) Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available? Eur J Gastroenterol Hepatol 21(1):76-91. doi:10.1097/MEG. 0b013e32830ce 7ba
107. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1):71-78. doi:10.1038/nrc1256
108. Pounder RE, Ng D (1995) The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 9(Suppl 2):33-39
109. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ (2008) Efficient tumour form ation by single human melanoma cells. Nature 456(7222):593-598. doi:10.1038/nature07567
110. Rajnakova A, Moochhala S, Goh PM, Ngoi S (2001) Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett 172(2):177-185
111. Ristima ki A, Honkanen N, Jankala H, Sipponen P, Harkonen M (1997) Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57(7):1276-1280
112. Rius J, Guma M, Schachtrup C, Akasso glou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M (2008) NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453(7196):807-811. doi:10.1038/nature06905
113. Rocha FT, Lourenco LG, Juca MJ, Costa V, Leal AT (2009) Chemoprevention by celecoxib in refluxinduced gastric adenocarcinoma in Wistar rats that underwent gastrojejunostomy. Acta Ciru rgica Bras/Sociedade Brasileira para Desenvolvimento Pesquisa em Cirurgia 24(3):189-194
114. Saito H, Tsujitani S, Oka S, Kondo A, Ikeguchi M, Maeta M, Kaibara N (1999) The expression of transfor ming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 86(8):1455-1462
115. Sato H, Ishihara S, Kawashima K, Moriyama N, Suetsugu H, Kazumori H, Okuyama T, Rumi MA, Fukuda R, Nagasue N, Kinoshita Y (2000) Expression of peroxisome proliferator-activated receptor (PPAR) gamma in gastric cancer and inhib itory effects of PPARgamma agonists. Br J Cancer 83(10):1394-1400. doi:10.1054/bjoc.2000.1457
116. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M (1992) TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic " sphingomyelin breakdown. Cell 71(5):765-776
117. Shin SK, Li MS, Fuerst F, Hotchkiss E, Meyer R, Kim IT, Goel A, Boland CR (2006) Oncogenic T-antigen of JC virus is present frequently in human gastric cancers. Cancer 107(3):481-488. doi:10.1002/cncr.22028
118. Shiotani A, Uedo N, Iishi H, Murao T, Kanzaki T, Kimura Y, Kamada T, Kusunoki H, Inoue K, Haruma K (2012) H. pylori eradication did not improve dysregulation of specific oncogenic miRNAs in intestinal metaplastic glands. J Gastroenterol 47(9):988-998. doi :10.1007/s00535-012-0562-7
119. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thur ston G,Yancopoulos GD, D'Angelica M, Kemeny N, Lyden D, Rafii S (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Investi g 118(6):2111-2120. doi:10.1172/JCI34401
120. Slack JM (1986) Epithelial metaplasia and the second anatomy. Lancet 2(8501):268-271
121. Soutto M, Belkhiri A, Piazuelo MB, Schneider BG, Peng D, Jiang A, Washington MK, Kokoye Y, Crowe SE, Zaika A, Correa P, Peek RM Jr, El-Rifai W (2011) Loss of TFF1 is associated with activation of NF-kappaB-mediated inflammation and gastric neoplas ia in mice and humans. J Clin Investig 121(5):1753-1767. doi:10.1172/JCI43922
122. Sun P, Ben Q, Tu S, Dong W, Qi X, Wu Y (2011) Serum interleukin-33 levels in patients with gastric cancer. Dig Dis Sci 56(12):3596-3601. doi:10.1007/s10620-011-1760-5
123. Szaflarska A, Szczepanik A, Siedlar M, Czupryna A, Sierzega M, Popiela T, Zembala M (2009) Preoperative plasma level of IL-10 but not of proinflammatory cytokines is an independent prognostic factor in patients wit h gastric cancer. Anticancer Res 29(12):5005-5012
124. Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fuji ta H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Arisawa T (2010) Association between IL-17A,-17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer. Int J Mol Med 25(3):471-47 7
125. Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Ar isawa T (2011) Effect of IL-1beta and TNF-alpha polymorphisms on the prognosis and survival of gastric cancer patients. Clin Exp Med 11(4):211-217. doi:10.1007/s10238-010-0129-y
126. Takahashi T, Nau MM, C hiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF, Minna JD (1989) p53: A frequent target for genetic abnormalities in lung cancer. Science 246(4929):491-494
127. Takahashi N, Okumura T, Motomura W, Fujimoto Y, Kawabata I, Kohgo Y (1999) Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett 455(1-2):135-139
128. Taketo MM (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst 90(21):1609-1620
129. Thiel A, Mrena J, Ristimaki A (2011) Cyclooxygenase-2 and gastric cancer. Cancer Metastasis Rev 30(3-4):387-395. doi:10.1007/s10555-011-9312-1
130. Tsujimoto H, Ono S, Ichikura T, Matsumoto Y, Yamamoto J, Hase K (2010) Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes? Gastric Cancer (Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association) 13(4):212-221. doi:10.1007/s10120-010-0568-x
131. Uefuji K, Ichikura T, Mochizuki H (2005) Increased expression of interleukin-1alpha and cyclooxygenase-2 in human gastric cancer: a possible role in tumor progression. Anticancer Res 25(5):3225-3230
132. Ushiku T, Chong JM, Uozaki H, Hino R, Chang MS, Sudo M, Rani BR, Sakuma K, Nagai H, Fukayama M (2007) p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 120(1):60-66. doi:10.1002/ijc.22275
133. Vafa O, Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM (2002) c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 9(5):1031-1044
134. Valko M, Morris H, Cronin MT (2005) Metals, toxicity and oxidative stress. Curr Med Chem 12(10):1161-1208
135. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160(1):1-40. doi:10.10 16/j.cbi.2005.12.009
136. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44-84. doi:10.1016/j.biocel.2006.07.001
137. Velnar T, Bailey T, Smrkolj V (2009) The wound healing process: an overview of the cellular and molecular mechanisms. J Int M Res 37(5):1528-1542
138. Vries RG, Huch M, Clevers H (2010) Stem cells and cancer of the stomach and intestine. Mol Oncol 4(5):373-384. doi:10.1016/j.molonc.2010.05.001
139. Wang P, Xia HH, Zhang JY, Dai LP, Xu XQ, Wang KJ (2007) Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int J Cancer 120(3):552-562. doi:10.1002/ijc.22353
140. Wiseman M (2008) The second W orld Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 67(3):253-256. doi:10.1017/S002966510800712X
141. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS, China Gastric Cancer Study G (2004) Helicobacter pylori era dication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291(2):187-194. doi:10.1001/jama.291.2.187
142. Wu CW, Chi CW, Hsieh MC, Chao MF, Lui WY, P'Eng FK (1998) Serum tumor necrosis factor in patients with gastric cancer. Anticancer Res 18(3A):1597-1599
143. Xu W, Li Y, Wang X, Chen B, Liu S, Wang Y, Zhao W, Wu J (2010) PPARgamma polymorph isms and cancer risk: a meta-analysis involving 32,138 subjects. Oncol Rep 24(2):579-585
144. Yamaoka Y (2010) Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 7(11):629-641. doi:10.1038/nrgastro.2010. 154
145. Yanaoka K, Oka M, Yoshimura N, Deguchi H, Mukoubayashi C, Enomoto S, Maekita T, Inoue I, Ueda K, Utsunomiya H, Iguchi M, Tamai H, Fujis hiro M, Nakamura Y, Tsukamoto T, Inada K, Takeshita T, Ichinose M (2010) Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negat ive precancerous lesion. Int J Cancer 126(6):1467-1473. doi:10.1002/ijc.24862
146. Yang XF (2007) Immunology of stem cells and cancer stem cells. Cell Mol Immunol 4(3):161-171
147. Ye ZB Ma T Li H Jin XL Xu HM 2007 Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma World J Gastroenterol13 11 1747-1751
148. Yerm ilov V, Rubio J, Becchi M, Friesen MD, Pignatelli B, Ohshima H (1995) Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis 16(9):2045-2050
149. Yin Y, Si X, Gao Y, Gao L, Wang J (2013) The nuclear factor-kappaB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma. Oncol Rep 29(1):34-38. doi:10.3892/or.2012. 2089
150. Ying L, Marino J, Hussain SP, Khan MA, You S, Hofseth AB, Trivers GE, Dixon DA, Harris CC, Hofseth LJ (2005) Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. Cancer Res 65(20):9132-9136. doi:10.1158/0008-5472. CAN-05-1358
151. Yokozaki H, Kuniyasu H, Semba S, Yasui W, Tahara E (1997) Molecular bases of human stomach carcinogenesis. In: Tahara E (ed) Molecular pathology of gastroenterological cancer. Springer, New York/Tokyo, pp 55-70
152. Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Zhang X, Shen Y, Qiang B, Kadlubar FF, Lin D (2005) Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology 129(2):565-576. doi:10.1016/j.gastro.2005.05.003
153. Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, Xiao S, Lu H (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest (A Journal of Tech nical Methods and Pathology) 88(12):1358-1366. doi:10.1038/labinvest.2008.94
154. Zhang LJ, Wang SY, Huo XH, Zhu ZL, Chu JK, Ma JC, Cui DS, Gu P, Zhao ZR, Wang MW, Yu J (2009) Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. World J Gastroenterol 15(22):2731-2738
155. Zhu Y, Wang J, He Q, Zhang JQ (2011) The association betw een interleukin-10-592 polymorphism and gastric cancer risk: a meta-analysis. Med Oncol 28(1):133-136. doi:10.1007/s12032-010-9417-3
156. Zhuang Y, Peng LS, Zhao YL, Shi Y, Mao XH, Chen W, Pang KC, Liu XF, Liu T, Zhang JY, Zeng H, Liu KY, Guo G, Tong WD, Shi Y, Tang B, Li N, Yu S, Luo P, Zhang WJ, Lu DS, Yu PW, Zou QM (2012) CD8(+) T cells that produce interleukin-17 regulate m yeloidderived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology 143(4):951-962, e958. doi:10.1053/j.gastro.2012.06.010
157. Zouki C, Jozsef L, Ouellet S, Paquette Y, Filep JG (2001) Peroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes. J Leukoc Biol 69(5):815-824